Prognosis of incidental lung cancer in lung transplant candidates
Lung cancer diagnosed during the medical evaluation of potential LTx candidates is rare. However, this represents a critical issue because it contraindicates LTx and leads to a non-optimal management of both lung cancer and of end-stage lung disease. We report an encouraging one-year survival rate in transplanted patients with a pathological lung malignancy diagnosis in lung explant, compared to their counterpart in whom lung cancer discovery contraindicated LTx. A multicenter observational study is mandatory in order to confirm such observation, as it might change current standard to deny LTx in patients with incidental localized NSCLC.
Authors
- G. Jébrak
- Chahine Medraoui
- Aurélie Cazes (ORCID: https://orcid.org/0000-0002-7172-9101)
- Clémentine Bouchez
- V. Gounant (ORCID: https://orcid.org/0000-0002-9473-1247)
- Gérard Zalcman
- Philippe Montravers (ORCID: https://orcid.org/0000-0002-3422-5705)
- Antoine Khalil (ORCID: https://orcid.org/0000-0001-9804-0577)
- Jonathan Messika (ORCID: https://orcid.org/0000-0003-2123-3527)
- Pierre Mordant (ORCID: https://orcid.org/0000-0001-5716-4848)
- Yves Castier (ORCID: https://orcid.org/0009-0007-0170-1668)
- Hervé Mal (ORCID: https://orcid.org/0000-0002-5951-436X)
- Marie‐Pierre Revel (ORCID: https://orcid.org/0000-0001-7906-6499)
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Inserm (FR)
- Université Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Bichat-Claude-Bernard (FR)
Publication Details
- Journal
- Respiratory Medicine and Research
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1016/j.resmer.2024.101146
- Citations
- 1
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.57